Cas:32745-07-6 n-nitrosodimethyl-1,1,1-d3-amine manufacturer & supplier

We serve Chemical Name:n-nitrosodimethyl-1,1,1-d3-amine CAS:32745-07-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

n-nitrosodimethyl-1,1,1-d3-amine

Chemical Name:n-nitrosodimethyl-1,1,1-d3-amine
CAS.NO:32745-07-6
Synonyms:Nitrosomethyl-n-propylamine;Methylpropylnitrosoamine;methyl-nitroso-trideuteriomethyl-amine;N-nitrosomethylpropylamine;PROPYLAMINE,N-METHYL-N-NITROSO;Salpetrigsaeure-methylpropylamid;N-Nitrosomethyl-N-propylamine;N-Methyl-N-propylnitrosamine;Methyl-nitroso-propyl-amin;Nitrosomethylpropylamine;N-Nitroso-propyl-methylamin;Methylpropylnitrosamin;N-Nitroso-methyl-n-propylamin;Methyl-n-propylnitrosamine;N-Nitrozo-dimethylamin-d3;methyl-nitroso-propyl-amine;Methyl-<methyl-d3>-nitroso-amin;Methylpropylnitrosamine
Molecular Formula:C2H3D3N2O
Molecular Weight:77.10030
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:151.999ºC at 760 mmHg
Density:1.029 g/cm3
Index of Refraction:
PSA:32.67000
Exact Mass:77.06680
LogP:0.22940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Nitrosomethyl-n-propylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methylpropylnitrosamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nitrosomethylpropylamine Use and application,N-Nitrosomethyl-N-propylamine technical grade,usp/ep/jp grade.


Related News: The manufacturing chief pointed to some of the cutting-edge technology Takeda will roll out at the upgraded facility, such as automation and robotics, plus virtual reality equipment and training. sodium,4-methoxybenzoate manufacturers The business, home to popular brands such as arthritis gel Voltaren and vitamins line Centrum, generated over £10 billion in sales during 2020. 8-butan-2-ylquinoline suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 2-benzyl-3,3a,5,6,7,7a-hexahydro-1H-isoindol-4-one vendor & factory In addition, the government has made a series of new commitments, including:,The manufacturing chief pointed to some of the cutting-edge technology Takeda will roll out at the upgraded facility, such as automation and robotics, plus virtual reality equipment and training.